RISE Life Science Corp. reported earnings results for the third quarter and nine months ended August 31, 2021. For the third quarter, the company reported net loss was CAD 0.082234 million compared to CAD 0.845767 million a year ago. For the nine months, net income was CAD 4.78 million compared to net loss of CAD 2.13 million a year ago. Basic earnings per share from continuing operations was CAD 0.4 compared to basic loss per share from continuing operations of CAD 0.4 a year ago.